Skip to main content
. 2021 Sep 20;13:70. doi: 10.1186/s13321-021-00553-9

Fig. 5.

Fig. 5

The relationship between diseases that are associated with drug targets in #Cluster1, #Cluster2, #Cluster3, #Cluster4 and #Cluster5